Arginase/nitric oxide modifications using live non-pathogenic Leishmania tarentolae as an effective delivery system inside the mammalian macrophages

Arenberg DA, White ES, Burdick MD, Strom SR, Strieter RM (2001) Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10). Cancer Immunol Immunother 50(10):533–538 Barani S, Turki H, Shafiei R, Jafarzadeh F, Maleki HH, Raeghi S (2020) Clinico-Hematological Findings of Acute Pediatric Visceral Leishmaniasis Referred to the Northeast of Iran during 2005-2015. Iranian J Parasitol 15(2):214–222 Basile G, Peticca M (2009) Recombinant protein expression in Leishmania tarentolae. Mol Biotechnol 43(3):273 Behniafar H, Moin-Vaziri V, Mohebali M, Tabaei SJS, Zarei Z, Kazemirad E, Akhoundi B, Saharifi-Yazdi MK, Zahraei-Ramazani A (2019) Visceral leishmaniasis among children in an endemic area of northwestern Iran between 2016 and 2017: an epidemiological study. Asian Pacific J Trop Med 12(7):306 Bueno GCL, Koerich ATDS, Burg LB, Kretzer SL, Moral JÂGD, Pereira IA (2019) Visceral leishmaniasis mimicking systemic lupus erythematosus. Revista da Sociedade Brasileira de Medicina Tropical 52:195 Chaouch M, Aoun K, Ben Othman S, Ben Abid M, Ben Sghaier I, Bouratbine A, Ben Abderrazak S (2019) Development and assessment of Leishmania major and Leishmania tropica specific loop-mediated isothermal amplification assays for the diagnosis of cutaneous leishmaniasis in Tunisia. Am J Trop Med Hyg 101(1):101–107 Contreras-Zentella ML, Sánchez-Sevilla L, Suárez-Cuenca JA, Olguín-Martínez M, Alatriste-Contreras MG, García-García N, Orozco L, Hernández-Muñoz R (2019) The role of oxidant stress and gender in the erythrocyte arginine metabolism and ammonia management in patients with type 2 diabetes. PLoS ONE 14(7):e0219481 Datki Z, Olah Z, Macsai L, Pakaski M, Galik B, Mihaly G, Kalman J (2019) Application of BisANS fluorescent dye for developing a novel protein assay. PLoS ONE 14(4):e0215863 Genestra M, Guedes-Silva D, Souza WJS, Cysne-Finkelstein L, Soares-Bezerra RJ, Monteiro FP, Leon LL (2006a) Nitric oxide synthase (NOS) characterization in Leishmania amazonensis axenic amastigotes. Arch Med Res 37(3):328–333 Genestra M, Souza WJ, Guedes-Silva D, Machado GM, Cysne-Finkelstein L, Bezerra RJS, Monteiro F, Leon LL (2006b) Nitric oxide biosynthesis by Leishmania amazonensis promastigotes containing a high percentage of metacyclic forms. Arch Microbiol 185(5):348–354 Getaneh A, Tamrat A, Tadesse K (2015) Arginase activity in peripheral blood of patients with intestinal schistosomiasis, Wonji, Central Ethiopia. Parasite Immunol 37(7):380–383 Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P, Adhikari A, Mukherjee A, Bhattacharyya Majumdar S, Majumdar S (2009) CXC chemokine-mediated protection against visceral Leishmaniasis: involvement of the proinflammatory response. J Infect Dis 200(8):1300–1310 Hasan NA, Shafiei R, Reza HG, Reza ZE, Ashok A (2020) Cytokine profile and nitric oxide levels in peritoneal macrophages of BALB/c mice exposed to Fucose-Mannose Ligand of Leishmania infantum combined with Glycyrrhizin Hezari F, Niyyati M, Seyyed Tabaei SJ, Mohebali M, Moin Vaziri V, Behniafar H, Azargashb E, Taghipour N (2016) Frequency of cutaneous Leishmaniasis and species identification in suspected individuals from Golestan Province, Northern Iran in 2014. Iranian J Public Health 45(10):1348–1354 Ibarra-Meneses AV, Ghosh P, Hossain F, Chowdhury R, Mondal D, Alvar J, Moreno J, Carrillo E (2017) IFN-γ, IL-2, IP-10, and MIG as biomarkers of exposure to Leishmania spp., and of cure in human visceral Leishmaniasis. Front Cellular Infect Microbiol 7(200):10196 Kang TH, Bae HC, Kim SH, Seo SH, Son SW, Choi EY, Seong SY, Kim TW (2009) Modification of dendritic cells with interferon-γ-inducible protein-10 gene to enhance vaccine potency. J Gene Med 11(10):889–898 Kima PE, Soong L (2013) Interferon gamma in Leishmaniasis. Front Immunol 4:156 Klatt S, Simpson L, Maslov DA, Konthur Z (2019) Leishmania tarentolae: taxonomic classification and its application as a promising biotechnological expression host. PLoS Negl Trop Dis 13(7):e0007424 Ko EM, Ma JH, Guo F, Miers L, Lee E, Bannerman P, Burns T, Ko D, Sohn J, Soulika AM (2014) Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. J Neuroinflammation 11(1):105 Krassner SM, Flory B (1971) Essential amino acids in the culture of Leishmania tarentolae. J Parasitol 15:917–920 Krathwohl MD, Anderson JL (2006) Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model. Vaccine 24(15):2987–2993 Liu D, Uzonna JE (2012) The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Front Cellular Infection Microbiol 2:83 Maritati M, Trentini A, Michel G, Bellini T, Almugadam S, Hanau S, Govoni M, Marty P, Contini C (2018) Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs. Infection 46(6):801–809 Masoori L, Kheirandish F, Haghighi A, Mohebali M, Akhoundi B, Taghipour N, Gachkar L, Chegeni-Sharafi A, Moin-Vaziri V (2018) Molecular-based detection of Leishmania infantum in human blood samples in a new focus of visceral Leishmaniasis in Lorestan Province, Iran. J Arthropod-Borne Dis 12(1):67 Montakhab-Yeganeh H, Abdossamadi Z, Zahedifard F, Taslimi Y, Badirzadeh A, Saljoughian N, Taheri T, Taghikhani M, Rafati S (2017) Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice. Parasite Immunol 39(10):e12461 Morales MA, Pescher P, Späth GF (2010) Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage. Eukaryot Cell 9(1):22–30 Moreira RRD, Santos AGD, Carvalho FA, Perego CH, Crevelin EJ, Crotti AEM, Cogo J, Cardoso MLC, Nakamura CV (2019) Antileishmanial activity of Melampodium divaricatum and Casearia sylvestris essential oils on Leishmania amazonensis. Revista do Instituto de Medicina Tropical de São Paulo 61:288 Ng KP, Manjeri A, Lee LM, Chan ZE, Tan CY, Tan QD, Majeed AQ, Lee KL, Chuah C, Suda T, Ong ST (2018) The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target. PLoS ONE 13(10):e0205254 Oliaee RT, Sharifi I, Afgar A, Jafarzadeh A, Kareshk AT, Bamorovat M, Sharifi H, Babaei Z, Keyhani A, Keyhani A, Abedi L, Sharifi F (2019) Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica. Microb Pathog 126:368–378 Pawar H, Puri M, Fischer Weinberger R, Madhubala R, Zilberstein D (2019) The arginine sensing and transport binding sites are distinct in the human pathogen Leishmania. PLoS Neglected Trop Dis 13(4):e0007304 Pereira MA, Alexandre-Pires G, Câmara M, Santos M, Martins C, Rodrigues A, Adriana J, Passero LFD, Pereira da Fonseca I, Santos-Gomes G (2019) Canine neutrophils cooperate with macrophages in the early stages of Leishmania infantum in vitro infection. Parasite Immunol 41(4):e12617 Shafiei R, Ahmadabad Hasan N, Nezafat Firizi M, BakhshiJoibari F, Ghahremani A, Hatam GR, Ghatee MA (2019) Cytokine profile and nitric oxide levels in macrophages exposed to Leishmania infantum FML. Exp Parasitol 203:1–7 Silva JMD, Silva HALD, Zelenski C, Souza JADM, Hueb M, Damazo AS (2019) Analysis of macrophage subtypes and annexin A1 expression in lesions of patients with cutaneous leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical 52:909 Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, Lawrence K, McCarthy WF, Adams RC, Scott C, Ransom J, Tang D, Grogl M (2019) Topical paromomycin for New World cutaneous leishmaniasis. PLoS Neglected Trop Dis 13(5):e0007253 Taslimi Y, Zahedifard F, Habibzadeh S, Taheri T, Abbaspour H, Sadeghipour A, Mohit E, Rafati S (2016) Antitumor effect of IP-10 by using two different approaches: live delivery system and gene therapy. J Breast Cancer 19(1):34–44 Toepp AJ, Bennett C, Scott B, Senesac R, Oleson JJ, Petersen CA (2019) Maternal Leishmania infantum infection status has significant impact on leishmaniasis in offspring. PLoS Neglected Trop Dis 13(2):e0007058 Vasquez RE, Soong L (2006) CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice. Infect Immun 74(12):6769–6777 Wanasen N, Soong L (2008) L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol Res 41(1):15–25 Yao C, Chen Y, Sudan B, Donelson JE, Wilson ME (2008) Leishmania chagasi: homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model. Exp Parasitol 118(1):129–133 Yue L, Yan M, Tremblay ML, Lin T-J, Li H, Yang T, Song X, Xie T, Xie Z (2019) PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils. PLoS ONE 14(9):e0222753